Loading...

PD-1/PD-L1 inhibitors in multiple myeloma: The present and the future

The introduction of PD-1/PD-L1 pathway inhibitors has marked a significant milestone in the treatment of various types of solid tumors. The current situation in multiple myeloma (MM) is rather unclear, as distinct research groups have reported discordant results. This discrepancy dominantly concerns...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncoimmunology
Main Authors: Jelinek, T., Hajek, R.
Format: Artigo
Sprog:Inglês
Udgivet: Taylor & Francis 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5215080/
https://ncbi.nlm.nih.gov/pubmed/28123899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1254856
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!